Hi, what are you looking for?
Jewish Business News
Search results for "Pershing Square Capital "
Business
Senate lawmakers investigating price hikes by the embattled drugmaker Valeant Pharmaceuticals will also question one of the company’s leading investors, hedge fund manager William...
Business
Even for the beleaguered shareholders of Valeant Pharmaceuticals International Inc., Monday was an unusually bad day. The company’s biggest owner, investment firm Ruane Cunniff...
Business
William “Bill” Ackman, founder and chief executive officer of Pershing Square Capital Management has fallen out of a list of the top 20 best-performing...
Business
Citing tax reasons, Bill Ackman, the activist investor and a strong defender of Valeant Pharmaceuticals International, has reduced his firm’s stake in...
Business
Billionaire hedge fund investor William (Bill) Ackman, whose funds Pershing Square Capital Management have suffered double-digit losses this year, on Tuesday told investors that...
Court
A U.S. judge said Valeant Pharmaceuticals International Inc (VRX.TO) (VRX.N) and activist hedge fund manager William Ackman must face a lawsuit accusing them...
Business
Bill Ackman’s Pershing Square Capital, got pounded in September. The hedge fund was the best-performing last year, returning 40.4%. Last month the fund’s publicly...
Business
According to Ackman, Mondelez could become a buyout target at some point. “If you had to make a list of companies that Buffett would...
Mergers & Acquisitions
Teva will pay over $45 billion for the botox maker unit, report the "Wall Street Journal."
Business
Bill Ackman, the billionaire hedge fund manager who runs Pershing Square Capital Management, said China is a far bigger concern to markets than Greece...